A
Aquinox Pharmaceuticals
Discovering and developing novel drug candidates to treat inflammation and cancer. | Aquinox Pharmaceuticals
About Aquinox Pharmaceuticals
Aquinox Canadian Pharmacy, based in Vancouver, is a prominent online pharmacy dedicated to providing high-quality over-the-counter (OTC) and prescription drugs. The company prides itself on safety and quality, meticulously selecting suppliers to ensure customers receive top-notch products at affordable prices. With a catalog boasting over 1,700 items, Aquinox serves a diverse clientele, including individuals seeking cost-effective medication solutions and those requiring specific prescription drugs.
Operating in the regulated Canadian pharmaceutical market, Aquinox benefits from government-controlled drug pricing, which allows it to offer significant savings to its customers. This regulation ensures that medications are not only affordable but also meet stringent safety and quality standards. The company’s business model revolves around online sales, making it convenient for customers to access a wide range of medications from the comfort of their homes.
Aquinox generates revenue through the sale of these medications, leveraging its extensive online platform to reach a broad audience. The company’s focus on customer care is evident in its 24/7 availability, ensuring that clients receive support whenever they need it. This commitment to service, combined with the cost advantages of the Canadian pharmaceutical market, positions Aquinox as a reliable and customer-centric pharmacy.
The leadership team at Aquinox includes experienced professionals from various sectors of the pharmaceutical and venture capital industries, ensuring robust governance and strategic direction. This expertise supports the company’s mission to provide safe, high-quality, and affordable medications to its customers.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2004
- Headquarters
- Vancouver, Canada
- Listing
- IPO 2014
- Employees
- 7
- Open positions
- None listed
- Dealroom signal
- 27.0/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Inflammatory Diseases, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO EQUITYOther financing | Sep 2016 | $75M | — | Undisclosed | ↗ |
| POST IPO EQUITYOther financing | Sep 2015 | $85M | — | Cowen Group | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
| Year | Revenue | Growth |
|---|---|---|
| 2026 | $25M | 0% |
| 2025 | $25M | 0% |
| 2024 | $25M | 0% |
| 2023 | $25M | 0% |
| 2022 | $25M | 0% |
| 2021 | $25M | 0% |
| 2020 | $25M | — |
Growth signals
Latest recorded traffic for Aquinox Pharmaceuticals is 2.4K monthly website visits, down 20% over the last three months. Aquinox Pharmaceuticals's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Ventures West
Johnson & Johnson Development Corporation
BC Advantage Funds- PVPfizer Ventures
Series B and later1 investor entered at this stage
Cowen Group
Other known investors1 additional known investor
The University of British Columbia
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Aquinox Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aquinox Pharmaceuticals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.